Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti-PD-1-Based Immunotherapy as Curative-Intent Treatment.
Yu JH, Liao LE, Xiao BY, Zhang X, Wu AW, Cheng Y, Tang JH, Jiang W, Kong LH, Han K, Mei WJ, Hong ZG, Yang WJ, Li DD, Pan ZZ, Li YF, Zhang XS, Ding PR.
Yu JH, et al.
J Natl Compr Canc Netw. 2024 Mar 18:1-8. doi: 10.6004/jnccn.2023.7096. Online ahead of print.
J Natl Compr Canc Netw. 2024.
PMID: 38498975